生物学和治疗的交叉点:针对成人喘的2型治疗方法
Michael C Peters1, Sally E Wenzel2
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Lancet (London, England)
|February 3, 2020
概括
针对2型呼吸道炎症的新生物疗法为耐固醇喘患者提供了希望. 这些治疗解决了潜在的生物机制,提供了超越传统吸入性皮质类固醇的新选择.
科学领域:
- 肺病学
- 免疫学
- 药理学
背景情况:
- 喘包括可逆的气流阻塞,其中2型细胞因子 (IL-4,IL-5,IL-13) 起着关键作用.
- 通过减少呼吸道炎症,吸入性皮质类固醇是标准的喘治疗方法,但对许多患者无效.
- 固醇耐药性喘是一个重大挑战,治疗选择有限.
研究的目的:
- 审查针对喘2型呼吸道炎症的新生物药物.
- 强调这些新疗法背后的生物逻辑.
- 总结这些新兴喘治疗的临床疗效.
主要方法:
- 对喘近期治疗进展的文献综述.
- 分析2型炎症背后的生物机制.
- 对新生物药物的临床试验数据的评估.
主要成果:
- 针对IL-4,IL-5和IL-13通道的生物药物显示出有前途.
- 这些疗法为耐固醇喘患者提供了替代方案.
- 临床研究显示在特定喘表型中具有显著的疗效.
结论:
- 新的生物疗法代表了喘管理的范式转变.
- 针对2型炎症提供了先前耐药性喘的有效治疗.
- 进一步的研究将完善这些药物在个性化喘治疗中的使用.
相关概念视频
Asthma-II: Pathophysiology and Classification
3.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.5K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.5K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K


